Literature DB >> 11095479

Familial splenomegaly: macrophage hypercatabolism of lipoproteins associated with apolipoprotein E mutation [apolipoprotein E (delta149 Leu)].

T T Nguyen1, K E Kruckeberg, J F O'Brien, Z S Ji, P S Karnes, T B Crotty, I D Hay, R W Mahley, T O'Brien.   

Abstract

Splenomegaly with sea-blue histiocytes is not associated with dyslipidemia, except in severe cases of hypertriglyceridemia, Tangier disease, or lecithin cholesterol acyltransferase deficiency. We describe two kindreds in which the sea-blue histiocyte syndrome was associated with an apoE variant in the absence of severe dyslipidemia. Both patients presented with mild hypertriglyceridemia and splenomegaly. After splenectomy both patients developed severe hypertriglyceridemia. Pathological evaluation of the spleen revealed the presence of sea-blue histiocytes. A mutation of apoE was demonstrated, with a 3-bp deletion resulting in the loss of a leucine at position 149 in the receptor-binding region of the apoE molecule [apoE (delta149 Leu)]. Although both probands were unrelated, they were of French Canadian ancestry, suggesting the possibility of a founder effect. In summary, we describe two unrelated probands with primary sea-blue histiocytosis who had normal or mildly elevated serum triglyceride concentrations that markedly increased after splenectomy. In addition, we provide evidence linking the syndrome to an inherited dominant mutation in the apoE gene, a 3-bp deletion on the background of an apoE 3 allele that causes a derangement in lipid metabolism and leads to splenomegaly in the absence of severe hypertriglyceridemia.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11095479     DOI: 10.1210/jcem.85.11.6981

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  7 in total

1.  Fish Oil Lipid Emulsion-Associated Sea-Blue Histiocyte Syndrome in a Pediatric Patient.

Authors:  Ting Ting Wu; David S Hoff
Journal:  J Pediatr Pharmacol Ther       Date:  2015 May-Jun

2.  Familial hypercholesterolemia in an Iranian family due to a mutation in the APOE gene (first case report).

Authors:  Shahab Noorian; Rezvan Razmandeh; Roshanak Jazayeri
Journal:  J Diabetes Metab Disord       Date:  2022-03-10

3.  MicroCT liver contrast agent enhancement over time, dose, and mouse strain.

Authors:  Chris E Suckow; David B Stout
Journal:  Mol Imaging Biol       Date:  2008-01-16       Impact factor: 3.488

4.  Description of a large family with autosomal dominant hypercholesterolemia associated with the APOE p.Leu167del mutation.

Authors:  Marie Marduel; Khadija Ouguerram; Valérie Serre; Dominique Bonnefont-Rousselot; Alice Marques-Pinheiro; Knut Erik Berge; Martine Devillers; Gérald Luc; Jean-Michel Lecerf; Laurent Tosolini; Danièle Erlich; Gina M Peloso; Nathan Stitziel; Patrick Nitchké; Jean-Philippe Jaïs; Marianne Abifadel; Sekar Kathiresan; Trond Paul Leren; Jean-Pierre Rabès; Catherine Boileau; Mathilde Varret
Journal:  Hum Mutat       Date:  2012-10-11       Impact factor: 4.878

5.  Hypertriglyceridemia and Recurrent Pancreatitis following Splenectomy.

Authors:  Michael Butman; David Taylor; Kristina Boström; Manuel Quinones; Susanne B Nicholas
Journal:  Case Rep Gastroenterol       Date:  2007-10-12

Review 6.  Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene.

Authors:  Britt E Heidemann; Charlotte Koopal; Alexis Baass; Joep C Defesche; Linda Zuurbier; Monique T Mulder; Jeanine E Roeters van Lennep; Niels P Riksen; Christopher Boot; A David Marais; Frank L J Visseren
Journal:  Clin Genet       Date:  2022-08-22       Impact factor: 4.296

7.  Differences in Recycling of Apolipoprotein E3 and E4-LDL Receptor Complexes-A Mechanistic Hypothesis.

Authors:  Meewhi Kim; Ilya Bezprozvanny
Journal:  Int J Mol Sci       Date:  2021-05-10       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.